vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与SITIME Corp（SITM）财务数据对比。点击上方公司名可切换其他公司
SITIME Corp的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$113.3M vs $75.5M），SITIME Corp同比增速更快（66.3% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $13.0M），过去两年SITIME Corp的营收复合增速更高（85.2% vs 31.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
SiTime是总部位于美国加利福尼亚州圣克拉拉的上市无晶圆厂芯片企业，专注于微机电系统（MEMS）技术研发，旗下相关产品可用作各类电子设备的计时器件，可覆盖通信、工业、消费电子等多个应用场景。
PBYI vs SITM — 直观对比
营收规模更大
SITM
是对方的1.5倍
$75.5M
营收增速更快
SITM
高出38.6%
27.7%
自由现金流更多
PBYI
多$1.4M
$13.0M
两年增速更快
SITM
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $113.3M |
| 净利润 | — | $9.2M |
| 毛利率 | 69.3% | 56.4% |
| 营业利润率 | 22.7% | 1.6% |
| 净利率 | — | 8.1% |
| 营收同比 | 27.7% | 66.3% |
| 净利润同比 | — | 148.7% |
| 每股收益（稀释后） | $0.26 | $0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISITM
| Q4 25 | $75.5M | $113.3M | ||
| Q3 25 | $54.5M | $83.6M | ||
| Q2 25 | $52.4M | $69.5M | ||
| Q1 25 | $46.0M | $60.3M | ||
| Q4 24 | $59.1M | $68.1M | ||
| Q3 24 | $80.5M | $57.7M | ||
| Q2 24 | $47.1M | $43.9M | ||
| Q1 24 | $43.8M | $33.0M |
净利润PBYISITM
| Q4 25 | — | $9.2M | ||
| Q3 25 | $8.8M | $-8.0M | ||
| Q2 25 | $5.9M | $-20.2M | ||
| Q1 25 | $3.0M | $-23.9M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | $20.3M | $-19.3M | ||
| Q2 24 | $-4.5M | $-26.8M | ||
| Q1 24 | $-4.8M | $-28.7M |
毛利率PBYISITM
| Q4 25 | 69.3% | 56.4% | ||
| Q3 25 | 77.7% | 53.5% | ||
| Q2 25 | 76.5% | 51.9% | ||
| Q1 25 | 77.1% | 50.3% | ||
| Q4 24 | 76.4% | 52.6% | ||
| Q3 24 | 63.9% | 51.1% | ||
| Q2 24 | 77.4% | 49.1% | ||
| Q1 24 | 75.5% | 53.5% |
营业利润率PBYISITM
| Q4 25 | 22.7% | 1.6% | ||
| Q3 25 | 17.6% | -19.2% | ||
| Q2 25 | 12.7% | -35.4% | ||
| Q1 25 | 8.7% | -46.6% | ||
| Q4 24 | 22.6% | -33.8% | ||
| Q3 24 | 27.4% | -43.1% | ||
| Q2 24 | -4.6% | -73.7% | ||
| Q1 24 | -5.3% | -106.1% |
净利率PBYISITM
| Q4 25 | — | 8.1% | ||
| Q3 25 | 16.2% | -9.6% | ||
| Q2 25 | 11.2% | -29.0% | ||
| Q1 25 | 6.5% | -39.6% | ||
| Q4 24 | — | -27.6% | ||
| Q3 24 | 25.2% | -33.5% | ||
| Q2 24 | -9.6% | -61.0% | ||
| Q1 24 | -11.0% | -86.9% |
每股收益（稀释后）PBYISITM
| Q4 25 | $0.26 | $0.44 | ||
| Q3 25 | $0.17 | $-0.31 | ||
| Q2 25 | $0.12 | $-0.84 | ||
| Q1 25 | $0.06 | $-1.01 | ||
| Q4 24 | $0.40 | $-0.80 | ||
| Q3 24 | $0.41 | $-0.83 | ||
| Q2 24 | $-0.09 | $-1.16 | ||
| Q1 24 | $-0.10 | $-1.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | — |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $1.2B |
| 总资产 | $216.3M | $1.3B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYISITM
| Q4 25 | $97.5M | — | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | — | ||
| Q1 24 | $107.2M | — |
总债务PBYISITM
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYISITM
| Q4 25 | $130.3M | $1.2B | ||
| Q3 25 | $115.3M | $1.1B | ||
| Q2 25 | $104.7M | $1.1B | ||
| Q1 25 | $97.1M | $692.5M | ||
| Q4 24 | $92.1M | $699.7M | ||
| Q3 24 | $71.1M | $696.2M | ||
| Q2 24 | $48.5M | $692.5M | ||
| Q1 24 | $51.0M | $696.2M |
总资产PBYISITM
| Q4 25 | $216.3M | $1.3B | ||
| Q3 25 | $202.9M | $1.3B | ||
| Q2 25 | $194.9M | $1.3B | ||
| Q1 25 | $196.2M | $872.1M | ||
| Q4 24 | $213.3M | $885.0M | ||
| Q3 24 | $220.7M | $877.9M | ||
| Q2 24 | $205.0M | $878.6M | ||
| Q1 24 | $214.1M | $942.6M |
负债/权益比PBYISITM
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $25.4M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $13.0M |
| 自由现金流率自由现金流/营收 | 19.1% | 11.5% |
| 资本支出强度资本支出/营收 | 0.0% | 10.9% |
| 现金转化率经营现金流/净利润 | — | 2.77× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $35.1M |
8季度趋势，按日历期对齐
经营现金流PBYISITM
| Q4 25 | $14.4M | $25.4M | ||
| Q3 25 | $9.7M | $31.4M | ||
| Q2 25 | $14.1M | $15.3M | ||
| Q1 25 | $3.6M | $15.0M | ||
| Q4 24 | $15.6M | $13.5M | ||
| Q3 24 | $11.0M | $8.2M | ||
| Q2 24 | $1.0M | $-181.0K | ||
| Q1 24 | $11.2M | $1.7M |
自由现金流PBYISITM
| Q4 25 | $14.4M | $13.0M | ||
| Q3 25 | $9.7M | $26.3M | ||
| Q2 25 | $14.1M | $-2.9M | ||
| Q1 25 | $3.6M | $-1.3M | ||
| Q4 24 | $15.6M | $-2.4M | ||
| Q3 24 | $11.0M | $-6.7M | ||
| Q2 24 | $1.0M | $-2.7M | ||
| Q1 24 | — | $-1.2M |
自由现金流率PBYISITM
| Q4 25 | 19.1% | 11.5% | ||
| Q3 25 | 17.7% | 31.5% | ||
| Q2 25 | 26.8% | -4.2% | ||
| Q1 25 | 7.7% | -2.1% | ||
| Q4 24 | 26.4% | -3.5% | ||
| Q3 24 | 13.7% | -11.6% | ||
| Q2 24 | 2.1% | -6.3% | ||
| Q1 24 | — | -3.6% |
资本支出强度PBYISITM
| Q4 25 | 0.0% | 10.9% | ||
| Q3 25 | 0.0% | 6.1% | ||
| Q2 25 | 0.0% | 26.2% | ||
| Q1 25 | 0.1% | 27.0% | ||
| Q4 24 | 0.0% | 23.3% | ||
| Q3 24 | 0.0% | 25.7% | ||
| Q2 24 | 0.0% | 5.8% | ||
| Q1 24 | 0.0% | 8.8% |
现金转化率PBYISITM
| Q4 25 | — | 2.77× | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
